Document:

THIS CONVERTIBLE NOTE PURCHASE AND CONVERSION
AGREEMENT (this “Agreement”) dated as of June 4, 2015 by and between H. Deworth Williams, with offices for
purposes of this Agreement at 2681 East Parleys Way, Suite 204, SLC, UT 84109 (“Seller”), and each of the Purchasers
set forth on Annex I attached hereto (each a “Purchaser,” and collectively, the “Purchasers”).

 

WHEREAS, Seller
owns and is selling pursuant to this Agreement in the amounts, to the Purchasers and for the purchase prices set forth on Annex
I to this Agreement, a certain convertible note of the Company (the “Note”), acquired by the Seller
on or about September 3, 2013; and on or about July 3, 2014, the Seller assigned $60,000 aggregate principle amount under the Note
to a third party;

 

WHEREAS, the Company’s
common stock (the “Common Stock”) is registered pursuant to Section 12 of the Securities Exchange Act
of 1934, as amended (the “Exchange Act”), and is quoted on the OTCQB under the symbol “UPNT.”

 

WHEREAS, Purchasers
desire to purchase and Seller agrees to assign, convey and sell all right, title and interest in and to the Note, including the
principal amount and all accrued interest as of the effective date of this Agreement, all on the terms and conditions set forth
herein;

 

WHEREAS, simultaneously
with the Closing (as defined below) and the purchase of the Note by the Purchasers from the Seller, the Note shall automatically
be converted into an aggregate of 10,000,000 pre 10 for 1 reverse split restricted shares of Common Stock in such amounts per Purchaser
as set forth on Annex I hereto.

 

WHEREAS, a copy
of the original Note is attached hereto as Exhibit “A”, a copy of which is also available on the Company’s
SEC EDGAR filings;

 

WHEREAS, a copy
of the original Note holder’s assignment of the Note to Seller on September 3, 2013 is attached hereto as Exhibit “B”;

 

WHEREAS, a copy
of Seller’s assignment of $60,000 in principal on the Note, bearing interest at 8% per annum, to the third party on July
3, 2014, is attached hereto as Exhibit “C”, the Seller thereby retaining the remainder of the Note; and

 

WHEREAS, Seller
is an “affiliate” and control person of the Company as defined in SEC Rules and therefore, Purchasers will not be able
to “tack” Seller’s holding period on the Note under state and federal securities laws but will commence a new
holding period of their own;

 

NOW, THEREFORE,
it is agreed:

 

	 	1.	Definitions. As used herein, the following terms shall have the meanings set forth below:

 

(a)               
“Applicable Law” means any domestic or foreign law, statute, regulation, rule or ordinance applicable
to the businesses or corporate existence of UPNT or to any individual who is a party to this Agreement.

 

(b)              
The “Company” or “UPNT” means Uplift Nutrition Inc., a publicly held Nevada corporation

 

(c)               
“Conversion Shares” means the shares of restricted Common Stock issued to each Purchaser upon the automatic
conversion of each Purchaser’s purchased portion of the Note.

 

(d)              
“Lien” means, with respect to any property or asset (including, but not limited to, stock certificates
or other securities), any mortgage, lien, pledge, charge, security interest, claim, encumbrance, royalty interest, any other adverse
claim of any kind in respect of such property or asset, or any other restrictions or limitations of any nature whatsoever.

 

(e)               
“Material Adverse Effect” with respect to any entity or group of entities means any event, change or
effect that has or would have a materially adverse effect on the financial condition, business or results of operations of such
entity or group of entities, taken as a whole.

 

(f)               
“Stock Purchase Agreement” or “SPA” means the Stock Purchase Agreement dated the date
hereof by and between the purchaser and sellers named therein, pursuant to which such sellers shall sell to such purchaser and
such purchaser shall purchase from such sellers 9,476,150 shares of issued and outstanding restricted Common Stock, substantially
simultaneously with the Closing of the sale of the Note herein from the Seller to the Purchasers and the automatic simultaneous
conversion of such Note into Conversion Shares pursuant to this Agreement, which 9,476,150 shares as of the date of this Agreement
represent in excess of a majority of the issued and outstanding shares of voting stock of the Company.

 

(g)              
“Tax” (and, with correlative meaning, “Taxes” and “Taxable”) means:

 

(i) any income,
alternative or add-on minimum tax, gross receipts tax, sales tax, use tax, ad valorem tax, transfer tax, franchise tax, profits
tax, license tax, withholding tax, payroll tax, employment tax, excise tax, severance tax, stamp tax, occupation tax, property
tax, environmental or windfall profit tax, custom, duty or other tax, impost, levy, governmental fee or other like assessment or
charge of any kind whatsoever together with any interest or any penalty, addition to tax or additional amount imposed with respect
thereto by any governmental or Tax authority responsible for the imposition of any such tax (domestic or foreign), and

 

(ii) any liability
for the payment of any amounts of the type described in clause (i) above as a result of being a member of an affiliated, consolidated,
combined or unitary group for any Taxable period, and

 

(iii) any liability
for the payment of any amounts of the type described in clauses (i) or (ii) above as a result of any express or implied obligation
to indemnify any other person.

 

(h)              
“Tax Return” means any return, declaration, form, claim for refund or information return or statement
relating to Taxes, including any schedule or attachment thereto, and including any amendment thereof.

 

    	(1)

    	 

     

 

	 	2.	Purchase of the Note; Automatic Conversion. Seller shall sell to Purchasers, and Purchasers purchase from the Seller the Note for an aggregate purchase price of Fifty-One Thousand Sixty-One Dollars and No Cents ($51,061.00) (the “Purchase Price”), all as set forth on Annex I hereto, and Note or evidence thereof shall be delivered by Seller to the escrow agent below, free and clear of any and all Liens, encumbrances, and pre-emptive rights, rights of first refusal and/or similar rights. Each such Purchaser agrees that simultaneously with the Closing, each Purchaser’s portion of the Note purchased by each Purchaser from the Seller shall automatically be converted into restricted Conversion Shares in such amounts as to each Purchaser as set forth on Annex I hereto.

 

	 	3.	Deliveries to Escrow Agent; Etc. Promptly after the execution of this Agreement, Purchasers shall (i) deposit the Purchase Price in immediately available funds into the Lawyer’s Trust Account maintained by Jody Walker Esq. (the “Escrow Agent”), and (ii) provide to the Escrow Agent duly executed and notarized irrevocable proxy and lock-up agreement (each an “Irrevocable Proxy,” and collectively the “Irrevocable Proxies”) in the form substantially annexed hereto as Exhibit D, pursuant to which each Purchaser agrees (a) not to directly and/or indirectly sell, assign and/or otherwise transfer any Conversion Shares, and (b) provide to Sharon Will the right to vote all of the Conversion Shares of each Purchaser, as set forth in Annex I hereto, in both cases until time as provided in the Irrevocable Proxy and (iii) Seller shall send to the Escrow Agent the Note, together with assignment documents sufficient to legally transfer to each Purchaser each such Purchaser’s dollar amount of the portion of the Note each Purchaser is purchasing from the Seller as set forth on Annex I hereto (the “Note and Related Documents”). The Escrow Agent will hold the Note and Related Documents and Irrevocable Proxies in escrow pending the Closing of the sale of the Note and/or the termination of this Agreement. Upon receipt of notice of termination given by either party pursuant to Section 10 hereof, the Escrow Agent shall return the Note and the Related Documents to the Seller and return the aggregate Purchase Price to the Purchasers.

 

	 	4.	The Closing. The purchase and sale of the Note will be consummated (the “Closing”) promptly following the satisfaction of the conditions set forth in Section 9 hereof. The date of the Closing is referred to herein as the “Closing Date.” The Closing shall be effected as follows:

 

(a)   
On the Closing Date, the Seller shall deliver to the Escrow Agent the following documents and instruments (“Seller
Deliverables”):

 

                               
i.           
[INTENTIONALLY LEFT BLANK] ;

                             
ii.           
[INTENTIONALLY LEFT BLANK] ; and

 

                           
iii.           
a general release from the Seller (the “Seller’s General Releases”), in form satisfactory
to Purchasers of all claims and liabilities, if any, of UPNT to Seller, its Affiliates and related persons; including, but not
limited to, all obligations under the Note, which accrues interest at a rate of 8% per annum, which is in the principal amount
as follows: $41,312 aggregate principal amount as of December 31, 2014 and $47,311.67 aggregate principal amount as of March 31,
2015 (plus $2,463 of “accrued interest payable—related party” as of December 31, 2014 and a total of $3,395.07
in accrued interest payable as of March 31, 2015 which is reflected in the line items “Due to Related Party” in UPNT’s
audited balance sheet in its audited financial statements for the year ended December 31, 2014 included in UPNT’S Annual
Report on Form 10-K for year ended December 31, 2014 (the “2014 10-K”); which aggregate principal amount
of the Note has increased by $5,999.67 from December 31, 2014, through and including the Closing Date (excluding non-compounding
interest on such principal amount at the rate of 8% per annum, which the parties agree shall be $9,151), of which such $5,999.67
additional principal amount was a result of additional funds loaned to UPNT by Seller or his alter ego Blue Cap, a Nevada corporation,
which such $5,999.67 is reflected in bank statements provided to the Purchasers at or prior to Closing from HD Williams/Blue Cap
and UPNT showing $6,000 funds debited from Blue Cap’s bank account at Wells Fargo Bank, Salt Lake City, and $6,000 funds
credited to UPNT’s bank account Chase Bank, Salt Lake City, at March end 2015.

 

(b)  
On the Closing Date, the Escrow Agent, in breaking escrow, shall (i) deliver to each Purchaser (I) copies of Note and Related
Documents related to each such Purchaser’s purchased portion of the Note being purchased from the Seller as set forth opposite
each such Purchaser’s name on Annex I hereto (or by means of a letter executed by the Seller or its counsel setting forth
the dollar amount paid for each Purchaser’s purchased portion of the Note, the principal amount of the Note, and amount of
the Conversion Shares of each such Purchaser’s purchased portion of the Note was converted into, all of which amounts to
be the same amounts as set forth in Annex I hereto), and (II) the other Seller Deliverables, (ii) deliver to the Company and its
stock transfer agent copies of the Note and Related Documents for cancellation, (iii) deliver to Ms. Will the executed and dated
Irrevocable Proxies and (iv) thereupon bank wire the $51,061 Purchase Price to the Attorney Trust Account of Mabey & Coombs,
L.C., the Seller’s legal counsel with Chase Bank in Salt Lake City. The escrow agent shall not be required to wait for UPNT’s
transfer agent to physically issue the certificates representing the Conversion Shares and mail them out to each Purchaser before
escrow can be broken and the purchase price bank-wired to Seller’s counsel.

 

(c)   
The Company shall, simultaneously with the Closing, deliver to the Company’s transfer agent, Fidelity Transfer Company
in Salt Lake City, Utah, a letter from the Company (and/or if required by the Company’s transfer agent, a letter from the
Company’s legal counsel to the transfer agent), to issue to each Purchaser the number of restricted Conversion Shares set
forth opposite each Purchaser’s name on Annex I hereto (10,000,000 restricted Conversion Shares in the aggregate), which
represents all Conversion Shares issuable upon conversion by all Purchasers of each such Purchaser’s portion of the Note
purchased from the Seller at the Closing, which each Purchaser agrees shall be automatically and simultaneously converted into
the number of restricted Conversion Shares set forth on Annex I, and upon such conversion, the Note shall be immediately cancelled
by the Company and so reflected on the Company and the transfer agent’s books and records and without any further force or
effect. The Note will thereupon no longer appear on the Company’s financial statements. The transfer agent shall imprint
the stock certificates representing the Conversion Shares with appropriate restrictive legends as provided in Section 6(c) below,
the form and language of which shall be provided to the transfer agent by counsel. Once issued, the 10,000,000 restricted Conversion
Shares shall thereupon be mailed by the transfer agent to each Purchaser at the address reflected in Annex I hereto upon its receipt
of the Note and Related Documents and this Agreement and any corollary instructions. This paragraph shall operate as sufficient
instructions for the transfer agent to do so unless, as stated above, the transfer agent requires additional instructions from
Seller and/or the Company’s counsel.  

 

(d)  
Each of the parties hereto agrees to deliver such additional documents and instruments as may be necessary to carry out
the transaction contemplated by this Agreement.

 

    	(2)

    	 

     

 

	 	5.	Seller’s Representations and Warranties. 

(a)   
Seller’s Warranties Regarding UPNT. The Seller warrants and represent to each Purchaser that:

 

	 	(i)	Organization and Standing. UPNT is a corporation duly organized, validly existing and in good standing under the laws of the State of Nevada and has full power and authority to carry on its business as now conducted. UPNT is qualified to do business as a foreign corporation in every other state in which it operates to the extent required by the laws of such states. The copies of the Articles of Incorporation and Bylaws (each as amended through and including the Closing) of UPNT previously delivered to the Purchasers are true and complete as of the date hereof.

 

	 	(ii)	Capitalization. UPNT's entire authorized capital stock consists of 100,000,000 shares of common stock, par value $0.001 per share and 10,000,000 shares of preferred stock, par value $0.001 per share, the rights and preferences for which have not yet been established but which the Board has the power and authority to designate under Nevada law. As of the date hereof and at the Closing, the total issued and outstanding capital stock of UPNT shall consist of 13,892,597 shares of Common Stock, the same number of shares that have been issued and outstanding in UPNT since February 2014. As of the date hereof and at the Closing, there will be no other voting or equity securities of UPNT issued and outstanding, and no outstanding subscriptions, warrants, calls, options, rights, commitments or agreements by which UPNT is bound, the only exception being two Notes (the “2 Notes”) accruing interest at a rate of 8% per annum, one of which is the Note being sold to the Purchasers pursuant to this Agreement, the other being a note (the “Cowle Note”), in the principal amount of $60,000 as of both December 31, 2014 and March 31, 2015 (plus $7,967 of accrued and unpaid interest as of December 31, 2014 and a total of $9,151 of accrued and unpaid interest as of March 31, 2015), both Notes being reflected in the line items “Due to Related Party” and “Note Payable” in UPNT’s audited balance sheet in its audited financial statements for the year ended December 31, 2014 included in UPNT’S 2014 10-K.

 

	 	(iii)	Issuance of Shares. All outstanding shares of Common Stock have been duly authorized and validly issued, are fully paid and non-assessable, and were not issued in violation of any Applicable Law and are not subject to any rescission or similar rights.

 

	 	(iv)	Corporate Records. All of UPNT’s books and records, including, without limitation, its books of account, corporate records, minute book, stock certificate books and other records are up-to-date, complete and reflect accurately and fairly the conduct of its business in all material respects since its date of incorporation.

 

	 	(v)	Liabilities. UPNT will have no liabilities at Closing other than the principal amount and accrued but unpaid interest on the 2 Notes, as set forth in Section 5(a)(ii) above. The 2 Notes, only one of which is subject hereof, will be duly sold and assigned at or prior to Closing, leaving such purchasers of the 2 Notes as the only creditors of the Company.

	 	 	 

	 	(vi)	Agreements. At the Closing, UPNT will not be bound by any contract, agreement, lease, commitment, guarantee or arrangement of any kind, except as provided herein. It will, however, continue to maintain its marketing and distribution contracts intact in regards to its continued offer and sale of Gray-to-Great and Mitigators, including any other or additional products that UPNT may be marketing by the time of closing. These marketing/distribution agreements shall survive the Closing.

 

	 	(vii)	Taxes. UPNT has filed all Tax Returns that it is required to file with all governmental agencies, wherever situate, and has paid or accrued for payment all Taxes as shown on such Returns, except for Taxes being contested in good faith. There is no material claim for Taxes that is a Lien against the property of UPNT other than Liens for Taxes not yet due and payable.

 

	 	(viii)	Pending Actions. There are no legal actions, lawsuits, proceedings or investigations, either administrative or judicial, pending or threatened, against or affecting UPNT or against UPNT’s current or former Officers or Directors that arose out of their operation of UPNT. UPNT is not subject to any order, writ, judgment, injunction, decree, determination or award of any court, arbitrator or administrative, governmental or regulatory authority or body.

 

	 	(ix)	No Violation of Agreements. Neither the execution and delivery of this Agreement and the carrying out of its purposes by the Seller nor the execution and delivery and the carrying out of the agreements and performance of the obligations by UPNT as contemplated herein, will result in the breach of any of the terms or conditions of, or constitute a default under or violate, UPNT’s Certificate of Incorporation or Bylaws (each as amended through the Closing) or any agreement, lease, mortgage, bond, indenture, license or other document or undertaking, oral or written, to which UPNT is a party or is bound or may be affected, nor will such execution, delivery and carrying out violate any order, writ, injunction, decree, law, rule or regulation of any court, regulatory agency or other governmental body.

 

	 	(x)	Trading Status. UPNT’s common stock is listed for quotation on the OTCQB with OTC Markets Group, Inc., under the symbol “UPNT.” To the best of Seller’s knowledge, UPNT has not been threatened and is not subject to removal of its common stock from the OTCQB nor of any actions by the Seller or any other person that could result in the Common Stock no longer being eligible to be quoted on the OTCQB.

 

	 	(xi)	SEC Status. The common stock of UPNT is registered pursuant to Section 12(g) of the Securities and Exchange Act of 1934, as amended (the “Exchange Act”). During the prior 2 years, UPNT has filed all reports on a timely basis required by the applicable regulations of the SEC and is current in its SEC reporting requirements. All of the filings by UPNT under the Exchanges Act within the past two years were true, correct and complete in all material respects when filed to the best knowledge, information and belief of the Seller, were not misleading, and did not omit to state any material fact which was necessary to make the statements contained in such public filings not misleading in any material respect. While UPNT’s EDGAR filings check the “non-shell” box on EDGAR filing cover or caption sheets and while Seller has a good faith belief that UPNT has had continuous operations and non-nominal assets other than cash, Seller, currently an affiliate and “control person” of the Company, makes no warranty or guaranty that the Commission might not claim UPNT to be a “Shell Company” (as defined in Rule 405 of the Commission’s General Rules and Regulations.

 

	 	(xii)	Compliance with Laws. UPNT’s operations have been conducted in all material respects in accordance with all applicable statutes, laws, rules and regulations. UPNT is not in violation of any Applicable Law.

 

	 	(xiii)	Absence of Certain Changes or Events. Since December 31, 2014 and except as provided in the 2014 10-K:

 

(A)there has not been (i) any
change that has had or would have a Material Adverse Effect on the business, operations, properties, assets, or condition of UPNT
or (ii) any damage, destruction, or loss to UPNT (whether or not covered by insurance) materially and adversely affecting the business,
operations, properties, assets, or condition of UPNT;

 

(B)UPNT has not (i) declared
or made, or agreed to declare or make, any payment of dividends or distributions of any assets of any kind whatsoever to stockholders
or purchased or redeemed, or agreed to purchase or redeem, any outstanding capital stock; (ii) waived any rights of value which
in the aggregate are extraordinary or material considering the business of UPNT; or (iii) made any material change in its method
of management, operation, or accounting;

 

(C)UPNT has not become subject
to any law or regulation which has had or would in the future be substantially likely to have a Material Adverse Effect on UPNT.

 

    	(3)

    	 

     

 

	 	(xiv)	Consultants, Finders or Agents. See Section 7 below.

 

	 	(xv)	No Insurance. UPNT maintains no insurance, nor does it maintain any insurance in connection with its past marketing of X-Mint, Tonify, Gray-to-Great or Mitigators on the Internet through its website, www.upliftnutritioninc.com. UPNT maintains no such insurance because UPNT is informed that the companies that manufacture these products carry substantial products liability and other insurance and it is UPNT’s understanding that no such insurance is necessary or required for distributors of such products. Recently UPNT has discontinued offering X-Mint and Tonify on its website and has concentrated on sales of its other products, all as disclosed in the 2014 10-K.

 

	 	(xvi)	No Payments to Seller. Seller has not received, directly and/or indirectly, and Seller has no knowledge of any direct and/or indirect payment received from UPNT and/or any Affiliate (as defined in the Securities Act), employee, consultant, directors, officers, related party of UPNT and/or any affiliate of any such parties or any other person, any funds, securities and/or other items of value whether of UPNT or any third party related to, in connection with or arising out of the Note and/or representing repayment of any principal, payment or of any interest on the Note, and/or as an inducement to lend money to UPNT or otherwise; and all of the $101,312 ($60,000 + $41,312) aggregate principal amount of the 2 Notes as of December 31, 2014 (as increased by approximately $6,000 in principal loaned to the Company by HD Williams and/or his alter ego, Blue Cap, between December 31, 2014 and the Closing),represents actual cash loaned to the Company for working capital purposes of the Company and has not directly and/or indirectly been repaid.

 

	 	(xvii)	Certain Rights. Purchasers shall have no obligation to pay any finder’s fees, agent fees or commissions in connection with the purchase and sale of the Note herein. See Section 7 below.

 

	 	(xviii)	DTC Eligible. The shares of Common Stock are DTC eligible and DTC has not placed a freeze, chill and/or lock-down on the shares of Common Stock; and the Seller has no reason to believe that DTC has any grounds and/or intends to take any such action in the future to effectuate a freeze, chill, lockdown or to make the shares of Common Stock not DTC eligible.

 

	 	(xix)	No Warranties, by Seller, as to UPNT’s Ability to Pay Off Note in Cash After Closing. Concurrent with this transaction, certain UPNT shareholders, including Seller, are selling over 50% of the issued and outstanding shares of UPNT to certain purchasers. Accordingly, Seller will no longer be in control of the Company after the Closing. As a result, Seller, who will not be in control of the Company after Closing, can make no representation or warranty to Purchasers, directly or indirectly, as to the future ability of UPNT to pay back the Note in cash if that is what any Purchaser seeks in the future. Purchasers will be required to look to new management in that regard and not any warranty or representation of Seller.

 

	 	(xx)	No Bad Actor. None of the Seller, any of its predecessors, affiliates, or any director, executive officer, other officer of Seller or any beneficial owner (as that term is defined in Rule 13d-3 under the Securities Exchange Act of 1934, as amended) of 20% or more of Seller’s outstanding voting equity securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the Securities Act) connected with Seller in any capacity as of the date hereof (each, a “Seller Covered Person” and, together, “Seller Covered Persons”) is subject to any of the “Bad Actor” disqualifications described in Rule 506(d)(1)(i) to (viii) under the Securities Act (a “Disqualification Event”). The Seller has exercised reasonable care to determine (A) the identity of each person that is a Seller Covered Person; and (B) whether any Seller Covered Person is subject to a Disqualification Event. The Seller has complied, to the extent applicable, with its disclosure obligations under Rule 506(e) of the Securities Act, and has furnished to the Buyer a copy of any disclosures provided thereunder.

 

(b)  
Seller’s Warranties Regarding the Note and the Conversion Shares. Seller warrants and represents to
the Purchasers as follows:

 

	 	(i)	Title to Note. The Seller is the sole and exclusive beneficial and record owner of the Note, free and clear of all Liens (as defined above), encumbrances, and rights of first refusal, pre-emptive and similar rights. By the transfer of the Note hereby, each Purchaser will acquire sole and exclusive good and marketable title to his, her or its portion of the Note hereby conveyed to him or her, free and clear of all Liens, including but not limited to, pre-emptive rights, rights of first refusal and/or similar rights, except for restrictions imposed by applicable federal and state securities laws.
	 	 	 
	 	(ii)	No Consent. No consent, waiver, approval, order or authorization of, or registration, declaration or filing with, any court, administrative agency or commission or other non-U.S., U.S., state, county, local or other foreign governmental authority, instrumentality, agency or commission or any third party is required by or with respect to Seller in connection with the execution and delivery of this Agreement or the consummation of the transactions contemplated hereby, except for the filing of a report with the SEC on Form 8-K reporting a change in control and a Rule 14f-1 Information Statement, both of which UPNT intends to file in connection with a separate stock sale transaction. In addition, those directors and officers or other insiders or “affiliates” who will no longer have such status as a result of this transaction, shall file Final Form 4’s on Edgar within 2 days of the Closing.

 

 

	 	(iii)	Validity of Agreement. This Agreement has been duly executed by Seller and constitutes Seller’s valid and binding obligation, except to the extent limited by applicable bankruptcy, reorganization, insolvency, moratorium or other laws relating to or effecting generally the enforcement of creditors’ rights. The execution and delivery of this Agreement and the carrying out of its purposes will not result in the breach of any of the terms or conditions of, or constitute a default under or violate, any agreement, lease, mortgage, bond, indenture, license or other document or undertaking, oral or written, to which any Seller is a party or by which any Seller is bound or may be affected, nor will such execution, delivery and carrying out violate any order, writ, injunction, decree, law, rule or regulation of any court, regulatory agency or other governmental body.

 

	 	(iv)	Conversion Shares. The Conversion Shares when issued to each Purchaser shall be duly and validly authorized, fully paid and non-assessable and shall vest in each Purchaser absolute and 100% ownership of each such Purchaser's Conversion Shares free and clear of all Liens and other clouds on title and not subject to any right of first refusal, pre-emptive rights, rescission rights and/or other similar rights.

 

    	(4)

    	 

     

 

	 	6.	Purchasers’ Warranties. Each Purchaser represents and warrants to Seller, for each such Purchaser (and not for or about any other Purchaser) that:

 

(a)               
Own Account; Not for Distribution. Purchaser is acquiring its portion of the Note and the Conversion Shares set forth
on Annex I for his or her own account, for investment and not with a view to the sale or
distribution of all or any part of the Note. Upon Closing, no one other than each Purchaser will have any beneficial interest in
the Note, or portions thereof, or the Conversion Shares purchased by each Purchaser.

 

(b)              
Securities Not Registered. Purchasers understand that because neither the Note nor the Conversion Shares have been
registered under the Securities Act, each Purchaser must continue to bear the economic risk of the investment for an indefinite
time, and the Note or portions thereof and such Purchaser’s Conversion cannot be sold unless they are subsequently registered
or an exemption from registration is available.

 

(c)               
Legend. In addition to legends reflecting the items set forth in the Irrevocable Proxy and Sections 3(ii)(a) and
(b) of this Agreement (the “Other Legends”), each Purchaser also consents to the placing of a standard Securities
Act restrictive legend (a “1933 Act Legend,” and together with the Other Legends, collectively, the “Legends”)
on all Conversion Shares. As each Purchaser hereby acknowledges and understands that none of the Conversion Shares have been registered
under the Securities Act, and as each Purchaser has entered into this Agreement and an Irrevocable Proxy, each Purchaser hereby
consents to the placing of a stop transfer order on the books and records of UPNT and with the Company’s transfer agent against
the Conversion Shares reflecting the substance of the Legends, which Legends and stop transfer orders against the Conversion Shares,
shall remain in place and be effective with regard to the 1933 Act Legend and stop transfer order reflecting such 1933 Act Legend
until the Conversion Shares may be legally resold or distributed, and with regard to the Other Legends and stop transfer orders
reflecting the substance of the Other Legends, such Other Legends and related stock transfer orders shall remain in place and effective
until the time set forth in the Irrevocable Proxies, which removal of all the Legends and stop transfer orders shall require a
written legal opinion addressed to the Purchaser, the Company and the Company’s transfer agent from a legal counsel hired
and paid for by each Purchaser (which legal counsel and opinion must be reasonably acceptable to the Company) opining that all
such Legends and stop transfer orders may be removed and expressly indicating the reasons therefore, citing specific documents
and applicable laws, rules and regulations.

 

(d)              
Material Information. Purchasers hereby represent and warrant that he, she or it has been furnished with all information
which they deemed necessary to evaluate the merits and risks of the purchase of the Note and the Conversion Shares, or any portion
thereof, and that he, she or it has had the opportunity to ask questions and receive answers concerning the Note, the Conversion
Shares and UPNT from the officers and directors of UPNT, and to obtain any additional information concerning the Note or UPNT necessary
to verify the accuracy of the information furnished or made available in connection herewith. Each Purchaser is an “accredited
investor” as that term is defined in Rule 405 of the General Rules and Regulations of the Commission and as may be further
defined in all relevant state and federal securities laws, including the amendments thereto in the Frank-Dodd Financial Reform
Act of 2010, which excludes the equity in one’s personal residence in the calculation of net worth for “accredited
investor” purposes. Each Purchaser has also consulted with counsel in deciding to enter into this transaction and each Purchaser
warrants and represents that all questions of such counsel have been answered to counsel’s satisfaction.

 

(e)               
Sophistication. Each Purchaser has such knowledge and experience in financial and business matters so as to be capable
of utilizing said information to evaluate the risks of the prospective investment and to make an informed investment decision.
Purchasers are each able to bear the economic risk of his or her investment in the Note or any portion thereof and the Conversion
Shares.

 

(f)               
No Distribution. Purchasers agree that they will not sell or otherwise distribute all or any part of the Note or
any Conversion Shares until (1) there is an effective registration statement under the Securities Act and applicable state
securities laws covering any such transaction involving the Note, and the Conversion Shares or (2) UPNT receives an opinion
of legal counsel stating that such transaction is exempt from registration.

 

(g)           
Validity of Agreement. This Agreement has been duly executed by each Purchaser and constitutes his, her or its valid
and binding obligation, except to the extent limited by applicable bankruptcy, reorganization, insolvency, moratorium or other
laws relating to or effecting generally the enforcement of creditors’ rights. The execution and delivery of this Agreement
and the carrying out of its purposes will not result in the breach of any of the terms or conditions of, or constitute a default
under or violate, any agreement, lease, mortgage, bond, indenture, license or other material document or undertaking, oral or written,
to which each Purchaser is a party or is bound or may be affected, nor will such execution, delivery and carrying out violate any
order, writ, injunction, decree, law, rule or regulation of any court, regulatory agency or other governmental body.

 

(h)           
Reverse Stock Split. After the 14f-1 Information Statement mentioned above is effective, the newly appointed Board
of Directors agree to authorize a reverse split of UPNT’s shares on the basis of a 1-for-10 shares and also, if they so desire,
change the name of UPNT to a name of their choosing. This will require the filing a 14C Information Statement on EDGAR and mailing
the same out to the shareholders of UPNT. It will also require the written consents of a majority of the shareholders to accomplish
this corporate action under Nevada law given that Nevada law requires a Certificate of Amendment to Articles to effectuate a reverse
split that isn’t reducing the authorized shares. Such reverse split shall automatically reverse the Conversion Shares on
a 1 for 10 basis.

 

(i)             
Knowledge. Each Purchaser has reviewed a copy of, among other relevant documents, the Note and the Related Documents,
the Irrevocable Proxy and Lock-Up as well as a copy of Stock Purchase Agreement between the Company and MCB Network Corp. (the
“SPA”) and understands all of the terms and conditions of each.

 

    	(5)

    	 

     

 

	 	7.	Third Party Fee.  The persons identified as Sellers under the separate Stock Purchase Agreement referenced herein will pay a fee to one or more persons (the “3rd Parties”), in connection with that agreement (the “3rd Party Fee”), and, therefore, no such fee is or will be due and owing under this Agreement and in no event shall any Purchaser be required to pay a finder’s, agent’s or consulting fee or commission in connection with this Agreement. Each Purchaser hereby acknowledges, understands and agrees that the 3rd Party Fee payable to the 3rd Parties is in the aggregate (i) $30,000 in cash, and (ii) the right to purchase a $1,403.66 portion of the Cowle Note which $1,403.66 portion of the Cowle Note shall be convertible into 1,300,000 pre-split restricted shares of Common Stock. See the SPA.

 

8.Parties’ Covenants.

 

	 	(a)	Announcement. Prior to the Closing, no party hereto nor UPNT shall issue any press release or otherwise make any public statement with respect to this Agreement or the transactions contemplated hereby without the prior consent of the other parties (which consent shall not be unreasonably withheld), except as may be required by applicable law or securities regulation. The parties will, to the extent practicable, consult with each other before issuing, and provide each other the opportunity to review and comment upon, any such press release or other public statements with respect to this Agreement and the transactions contemplated hereby whether or not required by Applicable Law.

 

	 	(b)	Access to Information; Inspection by each Purchaser. Prior to the Closing, Seller will cause UPNT to make available for inspection by the Purchasers and each of them, during normal business hours, all of UPNT’s records regarding the securities of the Company and UPNT’s records (including tax records), books of account, premises, contracts and all other documents in UPNT’s possession or control that are reasonably requested by any Purchaser to inspect and examine the business and affairs of UPNT. Seller will cause UPNT’s managerial employees and regular independent accountants to be available upon reasonable advance notice to answer questions of the Purchasers concerning the Seller, the Note and/or any other securities of UPNT, and the business and affairs of UPNT. The Purchasers will treat and hold as confidential any information it receives from UPNT in the course of the reviews contemplated by this Section 8(b). No examination by the Purchasers will, however, constitute a waiver or relinquishment by the Purchasers of his, hers or their rights to rely on the Seller’s covenants, representations and warranties made herein or pursuant hereto.

 

9.Closing Conditions.

 

(a)               
Conditions Precedent to Obligations of Purchasers. The obligations of the Purchasers under this Agreement shall be
and are subject to fulfillment, prior to or at the Closing, of each of the following conditions:

 

	 	(i)	Representations and Warranties. The Seller’s representations set forth in Section 5 hereof shall be true and correct on the Closing Date, as if such representations and warranties had been made on and as of the Closing Date, and Seller shall have delivered to the Purchasers a certification to such effect.

 

	 	(ii)	Performance. The Seller shall have performed or complied with all agreements, terms and conditions required by this Agreement to be performed or complied with by him prior to or at the time of the Closing.

 

	 	(iii)	Material Changes. Since the date of this Agreement, UPNT shall not have suffered a Material Adverse Effect and, without limiting the generality of the foregoing, there shall be no pending litigation to which UPNT or Seller is a party which is reasonably likely to have a Material Adverse Effect on UPNT or to affect the ability of the Seller to sell his Note as contemplated herein.

 

	 	(iv)	Reporting and Trading Status, Etc. The Common Stock will continue to be listed for trading on the OTCQB, and bid and asked quotations shall be posted as of the Closing Date, the shares of Common Stock shall continue to be DTC eligible and DTC shall not have placed any freeze, chill or lock-down on the shares of Common Stock and the Company shall be current on all of its filings obligations with the Commission; and neither Seller nor the Purchasers shall have knowledge, as of Closing, of any facts or circumstances or reason to believe that any of such status will or could change in the foreseeable future.

 

	 	(v)	Election of Directors. The 2 UPNT current Directors shall have appointed all of the Purchasers’ nominees to the Board of UPNT, effective at such time as UPNT’s Rule 14f-1 Information Statement to be mailed to shareholders becomes effective by operation of law. Thereafter, such 2 UPNT current Directors’ resignations shall become automatically effective. Such newly appointed directors shall file Form 3’s on Edgar within 2 days of assuming their duties as Board Members. The resigning directors shall file “final” Form 4’s within 2 days of the date the 14f-1 is effective.

 

	 	(vi)	Documents Satisfactory. All documents and instruments to be delivered pursuant to this Agreement shall be reasonably satisfactory in substance and form to the Purchasers and Purchasers’ counsel, and the Purchasers and Purchasers’ legal counsel shall have received all such counterpart originals (or certified or other copies) of such documents as they may reasonably request.

 

(b)              
Conditions Precedent to Obligations of Seller. The obligations of Seller under this Agreement shall be and are subject
to fulfillment, prior to or at the Closing, of each of the following conditions:

 

	 	(i)	Representations and Warranties. The representations and warranties of the Purchasers set forth in Section 6 hereof shall be true and correct on the Closing Date, as if such representations and warranties had been made on and as of the Closing Date.

 

	 	(ii)	Performance. The Purchasers shall have performed or complied with all agreements, terms and conditions required by this Agreement to be performed or complied with by them prior to or at the time of the Closing.

 

	 	(iii)	Documents Satisfactory. All documents and instruments to be delivered pursuant to this Agreement shall be reasonably satisfactory in substance and form to Seller and his counsel, and Seller and his counsel shall have received all such counterpart originals (or certified or other copies) of such documents as they may reasonably request.

 

    	(6)

    	 

     

 

10.Termination. This
Agreement may be terminated at any time before or at Closing, by:

 

(a)   
The mutual agreement of the parties;

 

(b)  
Any party if the Closing has not occurred by May 30, 2015, unless that party caused the failure to close by its failure
to satisfy the covenants herein;

 

(c)   
Any party if any legal proceeding shall have been instituted or shall be imminently threatening to delay, restrain or prevent
the consummation of this Agreement or any material component thereof;

 

(d)  
The Seller, if the Purchasers shall have breached in any material respect any of their representations, warranties, covenants
or other agreements contained in this Agreement, and the breach cannot be or has not been cured within thirty (30) calendar days
after the giving of written notice by the Seller to the Purchasers; or

 

(e)   
The Purchasers, if Seller shall have breached in any material respect any of his representations, warranties, covenants
or other agreements contained in this Agreement, and the breach cannot be or has not been cured within thirty (30) calendar days
after the giving of written notice by the Purchasers to the Seller.

 

Upon termination of this
Agreement for any reason, in accordance with the terms and conditions set forth in this paragraph, each party shall bear all costs
and expenses as each party has incurred and no party shall be liable to the other for such costs and expenses. No party shall have
any further liability or obligation to any other party in the event of such a termination, except for their respective obligations
with respect to Confidential Information (as defined in Section 10 below).

 

11.Confidentiality. No party
will, nor will he permit any of his agents, or representatives to, use for any purpose (other than evaluation of the transactions
contemplated hereby) or disclose to any third parties, any “Confidential Information” regarding the other or the business
of the other. Confidential Information regarding UPNT shall consist of information obtained directly or indirectly from a party
to this Agreement in connection with the transactions contemplated herein, but shall not include: (a) any information that already
had become or later becomes publicly available; (b) any information that already had been or later is lawfully developed or obtained
by the party receiving the information from independent sources; or (c) any information the disclosure of which is required by
law including, but not limited to, Commission laws, rules and regulations regarding disclosure of information in Current Reports
on Form 8-K and periodic reports requested to be filed with the Commission. If this Agreement is terminated without consummation
of the stock purchase contemplated hereunder, each of the parties agrees to return or destroy all documents (including documents
stored in electronic media) containing or reflecting Confidential Information regarding the other and their respective businesses.

 

12.Notices. All
notices and other communications under this Agreement shall be in writing and shall be deemed to have been given or made as follows:

 

a.         
If sent by an overnight air courier with a national reputation, 2 business days after being sent;

 

b.           
If sent by facsimile transmission, when transmitted to the fax numbers noted below and receipt is confirmed by the fax machine;
or

 

c.            
If sent by email, when sent (but only if the Sender has written confirmation of such email transmission being sent), or

 

d.           
If personally delivered, when delivered.

 

    	(7)

    	 

     

 

All notices and other communications
under this Agreement shall be sent or delivered as follows:

 

If to the Purchasers, to:

 

As set forth on Annex
I hereto:

 

If to the Seller, to:

 

John Michael Coombs, Esq.

c/o MABEY & COOMBS,
L.C.

3098 South Highland Drive,
Suite 323

Salt Lake City, UT 84106-6001

Phone No. 801-467-2997

Facsimile: 801-467-3256

Email address: jmcoombs@sisna.com

 

If to the Escrow Agent, to:

 

J. M. Walker & Associates,
Attorneys At Law

Attn:  Jody M. Walker

7841 S. Garfield Way

Centennial, CO  80122

Phone: (303) 850-7637

Fax: (303) 482-2731

Email: jmwlkr85@gmail.com

	 	 	 

 

Each Party may change its address by written
notice in accordance with this Section.

 

13.Provisions Concerning
Escrow Agent.  The Escrow Agent shall perform her obligations hereunder subject to the following provisions.

 

(a)               
Scope of Duties. The duties of the Escrow Agent shall be entirely administrative in nature, and the Escrow Agent
shall have no fiduciary obligation to any party hereto. The Escrow Agent shall be obligated to act only in accordance with written
instructions received by him as provided herein, except that the Escrow Agent shall comply with any final and unappealable order,
judgment or decree of any court of competent jurisdiction received by him. No implied duties or obligations of any kind shall be
read into this Agreement.

 

(b)              
Limitation on Liability. In performing his duties hereunder, the Escrow Agent shall not incur any liability to anyone
for any damages, losses or expenses except for damages, losses or expenses resulting directly from the willful default, gross negligence
or fraud of the Escrow Agent. In no event will the Escrow Agent be liable for any special, consequential or punitive damages.

 

(c)               
Reliance on Counsel, etc. The Escrow Agent shall not in any case incur liability with respect to any action taken
or omitted in good faith upon advice of counsel, or any action taken or omitted in reliance upon any written notice, release or
other document provided to the Escrow Agent as to the genuineness of the signatures thereon, the authority of the signatories,
its due execution, the validity and effectiveness of its provisions, or the truth and accuracy of the information contained therein.

 

(d)              
Indemnification of Escrow Agent; Expenses. The Escrow Agent shall not be responsible for initiating any action, claim
or proceeding hereunder. The Purchasers and the Seller shall jointly and severally indemnify the Escrow Agent (and his heirs and
legal representatives) and hold him and them harmless from and against, any and all losses, damages, liability and expenses, including
attorney’s fees, incurred by the Escrow Agent in connection with the performance of his duties hereunder, including but not
limited to attorneys’ fees and other costs and expenses of defending against any claim of liability (except liability arising
out of the Escrow Agent’s fraud, willful default or gross negligence) arising out of this Agreement. The Escrow Agent shall
not be obligated to take any legal or other action hereunder which might in his judgment involve or cause him to incur any expense
or liability unless he shall have been furnished with acceptable indemnification.

 

(e)               
Disputes. In the event of any dispute between the parties, or if any conflicting demand shall be made upon the Escrow
Agent, the Escrow Agent shall not be required to determine the same or take any action thereon. Rather, the Escrow Agent may, at
his sole option, (a) retain the certificates for the Note and the other closing documents and instruments in his possession, without
liability to anyone, until such dispute shall have been settled or resolved; or (b) file a suit in interpleader in the Third Judicial
District Court in and for Salt Lake County, State of Utah, for the purpose of having the respective rights of the parties adjudicated.
The Escrow Agent may, upon initiation of such suit, deposit the Notes with the court and, upon giving notice thereof to the parties,
the Escrow Agent shall be fully released and discharged from all further obligations hereunder.

 

(f)               
Resignation. The Escrow Agent may resign at any time by delivering notice to the parties hereto. If the parties fail
to advise the Escrow Agent within ten business days as to the appointment of a successor, the Escrow Agent may, at his sole option,
(a) retain the Purchased Shares and the other closing documents and instruments in his possession, without liability to anyone,
until such appointment shall have been made; or (b) file a suit in interpleader in the Third Judicial District Court in and for
Salt Lake County, State of Utah, for the purpose of having a successor appointed. The Escrow Agent may, upon initiation of such
suit, deposit the Purchased Shares with the court and, upon giving notice thereof to the parties, the Escrow Agent shall be fully
released and discharged from all further obligations hereunder.

 

(g)              
Escrow Fees and Costs. The Escrow Agent is being paid its fees and costs incurred hereunder pursuant to the SPA by
the purchaser named in and pursuant to the SPA and, therefore, no party to this Agreement will be required to pay any fees or costs
in connection with the Escrow Agents duties and responsibilities hereunder.

 

14.Applicable
Law, Etc. This Agreement and
the terms and
conditions set forth herein,
shall be governed
by and construed
solely and exclusively
in accordance with
the internal laws of the State of
Utah without regard to the conflicts of laws
principles thereof. The parties hereto hereby expressly and
irrevocably agree that any suit
or proceeding arising directly and/or
indirectly pursuant to or under this
Agreement shall be brought solely in a federal or
state court located in Salt Lake County, State of Utah. By its execution hereof, the parties hereto covenant and
irrevocably submit to
the in personam jurisdiction
of the federal and state courts
located in Salt Lake County, State of
Utah and agree that any process
in any such action may be served upon any of them
personally, or by certified mail or
registered mail upon them or their agent,
return receipt requested, with the same
full force and effect as if personally
served upon them in Salt Lake County, State
of Utah. The parties hereto
expressly and irrevocably waive any claim that any such jurisdiction is not
a convenient forum for any such suit or proceeding
and any defense or lack of
in personam jurisdiction with respect thereto. In
the event of any such action or
proceeding, the party prevailing therein
shall be entitled to payment from
the other parties hereto of all
of its reasonable counsel fees and
disbursements.

15.Entire Agreement.
This Agreement (including the documents and instruments referred to in this Agreement) and the SPA contain the entire understanding
of the parties with respect to the subject matter contained in this Agreement, and supersedes and cancels all prior agreements,
negotiations, correspondence, undertakings and communications of the parties, oral or written, respecting such subject matter.

 

16.Amendment. Neither
this Agreement nor any provision may be amended or modified except by written agreement signed by the Parties hereto.

 

17.Counterparts.
This Agreement may be executed in multiple facsimile or original counterparts. Each of the counterparts shall be deemed an original,
and together they shall constitute one and the same binding Agreement, with one counterpart being delivered to each Party hereto.

 

 

 

 

 

 

[SIGNATURE PAGE TO
FOLLOW]

 

    	(8)

    	 

     

IN WITNESS WHEREOF, the parties have
executed this Agreement as of the date first appearing above.

 

PURCHASERS:

 

__________________________________

 

 

__________________________________

 

 

__________________________________

 

 

 

SELLER:

 

 

__________________________________

H. Deworth
Williams

 

 

 

The undersigned agrees to undertake the duties
and responsibilities of the Escrow Agent set forth in Section 13 above.

 

ESCROW
AGENT

 

 

______________________________

Jody Walker,
Esq.

 

 

 

 

    	(9)

    	 

     

EXHIBIT A

 

 

COPY OF ORIGINAL NOTE

 

    	(10)

    	 

     

EXHIBIT B

 

 

ASSIGNMENT DOCUMENTS
OF THE ORIGINAL

NOTE TO THE SELLER
DATED SEPTEMBER 3, 2013

 

 

    	(11)

    	 

     

 

EXHIBIT C

 

 

ASSIGNMENT DOCUMENTS FOR ASSIGNMENT OF $60,000

AGGREGATE PRINCIPAL AMOUNT OF THE NOTE FROM

SELLER TO EDWARD COWLE ON JULY 3, 2014

 

 

 

 

 

 

 

 

    	(12)

    	 

     

EXHIBIT D

 

FORM OF IRREVOCABLE PROXY AND

LOCK-UP AGREEMENTExhibit 4.29

 

Form of Representative’s Warrant
Agreement

 

THE REGISTERED HOLDER
OF THIS PURCHASE WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE WARRANT EXCEPT
AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR
HYPOTHECATE, OR CAUSE THIS PURCHASE WARRANT OR THE SECURITIES ISSUABLE HEREUNDER TO BE THE SUBJECT OF ANY HEDGING, SHORT SALE,
DERIVATIVE, PUT, OR CALL TRANSACTION THAT WOULD RESULT IN THE EFFECTIVE ECONOMIC DISPOSITION OF THIS PURCHASE WARRANT FOR A PERIOD
OF ONE HUNDRED EIGHTY DAYS FOLLOWING THE EFFECTIVE DATE (DEFINED BELOW) TO ANYONE OTHER THAN (I) AEGIS CAPITAL CORP. OR AN UNDERWRITER
OR A SELECTED DEALER IN CONNECTION WITH THE OFFERING, OR (II) A BONA FIDE OFFICER OR PARTNER OF AEGIS CAPITAL CORP. OR OF ANY SUCH
UNDERWRITER OR SELECTED DEALER.

 

THIS PURCHASE WARRANT
IS NOT EXERCISABLE PRIOR TO [________________] [DATE THAT IS ONE YEAR FROM THE EFFECTIVE DATE OF THE OFFERING]. VOID AFTER
5:00 P.M., EASTERN TIME, [___________________] [DATE THAT IS FIVE YEARS FROM THE EFFECTIVE DATE OF THE OFFERING].

 

COMMON STOCK PURCHASE WARRANT

 

For the Purchase of [•]
Shares of Common Stock

of

CRYOPORT, INC.

 

1.          Purchase
Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of Aegis Capital Corp. (“Holder”),
as registered owner of this Purchase Warrant, to Cryoport, Inc., a Nevada corporation (the “Company”), Holder
is entitled, at any time or from time to time from [________________] [DATE THAT IS ONE YEAR FROM THE EFFECTIVE DATE OF THE
OFFERING] (the “Commencement Date”), and at or before 5:00p.m., Eastern time, [____________] [DATE
THAT IS FIVE YEARS FROM THE EFFECTIVE DATE OF THE OFFERING] (the ”Expiration Date”), but not thereafter,
to subscribe for, purchase and receive, in whole or in part, up to [•]
shares of common stock of the Company, par value $0.001 per share (the “Shares”), subject to adjustment
as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close,
then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein.
During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant.
This Purchase Warrant is initially exercisable at $[•]
per Share [137.5% of the price of the Shares sold in the Offering]; provided, however, that upon the occurrence
of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per
Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise
Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.

 

    	1

    	 

    

  

2.           Exercise.

 

2.1         Exercise
Form. In order to exercise this Purchase Warrant, the exercise form attached hereto must be duly executed and completed and
delivered to the Company, together with this Purchase Warrant and payment of the Exercise Price for the Shares being purchased
payable in cash by wire transfer of immediately available funds to an account designated by the Company or by certified check or
official bank check. If the subscription rights represented hereby shall not be exercised at or before 5:00 p.m., Eastern time,
on the Expiration Date, this Purchase Warrant shall become and be void without further force or effect, and all rights represented
hereby shall cease and expire.

 

2.2         Cashless
Exercise.  If at any time after the Commencement Date there is no effective registration statement registering, or no
current prospectus available for, the resale of the Shares by the Holder, then in lieu of exercising this Purchase Warrant by payment
of cash or check payable to the order of the Company pursuant to Section 2.1 above, Holder may elect to receive the number of Shares
equal to the value of this Purchase Warrant (or the portion thereof being exercised), by surrender of this Purchase Warrant to
the Company, together with the exercise form attached hereto, in which event the issue to Holder, Shares in accordance with the
following formula:

 

	X	=	Y(A-B)	 
	A	 

 

	Where,	 	 	 
	 	X	=	The number of Shares to be issued to Holder;
	 	Y	=	The number of Shares for which the Purchase Warrant is being exercised;
	 	A	=	The fair market value of one Share; and
	 	B	=	The Exercise Price.

 

For purposes of this
Section 2.2, the fair market value of a Share is defined as follows:

 

(i)      if
the Company’s common stock is traded on a securities exchange, the value shall be deemed to be the closing price on such
exchange prior to the exercise form being submitted in connection with the exercise of the Purchase Warrant; or

 

(ii)     if
the Company’s common stock is actively traded over-the-counter, the value shall be deemed to be the closing bid prior to
the exercise form being submitted in connection with the exercise of the Purchase Warrant; if there is no active public market,
the value shall be the fair market value thereof, as determined in good faith by the Company’s Board of Directors.

 

2.3     Legend.
Each certificate for the securities purchased under this Purchase Warrant shall bear a legend as follows unless such securities
have been registered under the Securities Act of 1933, as amended (the “Act”):

 

“The securities
represented by this certificate have not been registered under the Securities Act of 1933, as amended (the “Act”),
or applicable state law. Neither the securities nor any interest therein may be offered for sale, sold or otherwise transferred
except pursuant to an effective registration statement under the Securities Act, or pursuant to an exemption from registration
under the Securities Act and applicable state law which, in the opinion of counsel to the Company, is available.”

 

    	2

    	 

    

  

3.           Transfer.

 

3.1          General
Restrictions. The registered Holder of this Purchase Warrant agrees by his, her or its acceptance hereof, that such Holder
will not: (a) sell, transfer, assign, pledge or hypothecate this Purchase Warrant for a period of one hundred eighty (180) days
following the Effective Date to anyone other than: (i) Aegis Capital Corp. (“Aegis”) or an underwriter or a
selected dealer participating in the Offering, or (ii) a bona fide officer or partner of Aegis or of any such underwriter or selected
dealer, in each case in accordance with FINRA Conduct Rule 5110(g)(1), or (b) for a period of one hundred eighty (180) days following
the Effective Date, cause this Purchase Warrant or the securities issuable hereunder to be the subject of any hedging, short sale,
derivative, put or call transaction that would result in the effective economic disposition of this Purchase Warrant or the securities
hereunder, except as provided for in FINRA Rule 5110(g)(2). On and after 180 days after the Effective Date, transfers to others
may be made subject to compliance with or exemptions from applicable securities laws. In order to make any permitted assignment,
the Holder must deliver to the Company the assignment form attached hereto duly executed and completed, together with the Purchase
Warrant and payment of all transfer taxes, if any, payable in connection therewith. The Company shall within five (5) Business
Days transfer this Purchase Warrant on the books of the Company and shall execute and deliver a new Purchase Warrant or Purchase
Warrants of like tenor to the appropriate assignee(s) expressly evidencing the right to purchase the aggregate number of Shares
purchasable hereunder or such portion of such number as shall be contemplated by any such assignment.

 

3.2          Restrictions
Imposed by the Securities Act. The securities evidenced by this Purchase Warrant shall not be transferred unless and until:
(i) the Company has received the opinion of counsel for the Holder that the securities may be transferred pursuant to an exemption
from registration under the Securities Act and applicable state securities laws, the availability of which is established to the
reasonable satisfaction of the Company (the Company hereby agreeing that the opinion of Bryan Cave LLP shall be deemed satisfactory
evidence of the availability of an exemption), or (ii) a registration statement or a post-effective amendment to the Registration
Statement relating to the offer and sale of such securities has been filed by the Company and declared effective by the U.S. Securities
and Exchange Commission (the ”Commission”) and compliance with applicable state securities law has been
established.

 

4.            Registration
Rights.

 

4.1          [Intentionally
Omitted.]

 

4.2          “Piggy-Back”
Registration.

 

4.2.1           Grant
of Right. For a period of no more than seven (7) years from the date of effectiveness of the registration statement in accordance
with FINRA Rule 5110(f)(2)(G)(v), to include the Shares underlying the Purchase Warrants (collectively, the “Registrable
Securities”) as part of any other registration of securities filed by the Company (other than in connection with a transaction
contemplated by Rule 145(a) promulgated under the Securities Act or pursuant to Form S-8 or any equivalent form); provided,
however, that if, solely in connection with any primary underwritten public offering for the account of the Company, the
managing underwriter(s) thereof shall, in its reasonable discretion, impose a limitation on the number of shares of Common Stock
which may be included in the Registration Statement because, in such underwriter(s)’ judgment, marketing or other factors
dictate such limitation is necessary to facilitate public distribution, then the Company shall be obligated to include in such
Registration Statement only such limited portion of the Registrable Securities with respect to which the Holder requested inclusion
hereunder as the underwriter shall reasonably permit. Any exclusion of Registrable Securities shall be made pro rata among the
Holders seeking to include Registrable Securities in proportion to the number of Registrable Securities sought to be included by
such Holders; provided, however, that the Company shall not exclude any Registrable Securities unless the Company
has first excluded all outstanding securities, the holders of which are not entitled to inclusion of such securities in such Registration
Statement or are not entitled to pro rata inclusion with the Registrable Securities.

 

    	3

    	 

    

  

4.2.2       Terms.
The Company shall bear all fees and expenses attendant to registering the Registrable Securities pursuant to Section 4.2.1 hereof,
but the Holders shall pay any and all underwriting commissions and the expenses of any legal counsel selected by the Holders to
represent them in connection with the sale of the Registrable Securities. In the event of such a proposed registration, the Company
shall furnish the then Holders of outstanding Registrable Securities with not less than thirty (30) days written notice prior to
the proposed date of filing of such registration statement. Such notice to the Holders shall continue to be given for each registration
statement filed by the Company until such time as all of the Registrable Securities have been sold by the Holder. The holders of
the Registrable Securities shall exercise the “piggy-back” rights provided for herein by giving written notice within
ten (10) days of the receipt of the Company’s notice of its intention to file a registration statement. Except as otherwise
provided in this Purchase Warrant, there shall be no limit on the number of times the Holder may request registration under this
Section 4.2.2; provided, however, that such registration rights shall terminate on the sixth anniversary of the Commencement
Date.

 

4.3         General
Terms.

 

4.3.1       Indemnification.
The Company shall indemnify the Holder(s) of the Registrable Securities to be sold pursuant to any registration statement hereunder
and each person, if any, who controls such Holders within the meaning of Section 15 of the Securities Act or Section 20 (a) of
the Securities Exchange Act of 1934, as amended (“Exchange Act”), against all loss, claim, damage, expense or
liability (including all reasonable attorneys’ fees and other expenses reasonably incurred in investigating, preparing or
defending against any claim whatsoever) to which any of them may become subject under the Securities Act, the Exchange Act or otherwise,
arising from such registration statement but only to the same extent and with the same effect as the provisions pursuant to which
the Company has agreed to indemnify the Underwriters contained in Section 5.1 of the Underwriting Agreement between the Underwriters
and the Company, dated as of [___________], 2015. The Holder(s) of the Registrable Securities to be sold pursuant to such
registration statement, and their successors and assigns, shall severally, and not jointly, indemnify the Company, against all
loss, claim, damage, expense or liability (including all reasonable attorneys’ fees and other expenses reasonably incurred
in investigating, preparing or defending against any claim whatsoever) to which they may become subject under the Securities Act,
the Exchange Act or otherwise, arising from information furnished by or on behalf of such Holders, or their successors or assigns,
in writing, for specific inclusion in such registration statement to the same extent and with the same effect as the provisions
contained in Section 5.2 of the Underwriting Agreement pursuant to which the Underwriters have agreed to indemnify the Company.

 

4.3.2       Exercise
of Purchase Warrants. Nothing contained in this Purchase Warrant shall be construed as requiring the Holder(s) to exercise
their Purchase Warrants prior to or after the initial filing of any registration statement or the effectiveness thereof.

 

    	4

    	 

    

  

4.3.3       Documents
Delivered to Holders. The Company shall furnish to each Holder participating in any of the foregoing offerings and to each
underwriter of any such offering, if any, a signed counterpart, addressed to such Holder or underwriter, of: (i) an opinion of
counsel to the Company, dated the effective date of such registration statement (and, if such registration includes an underwritten
public offering, an opinion dated the date of the closing under any underwriting agreement related thereto), and (ii) a “cold
comfort” letter dated the effective date of such registration statement (and, if such registration includes an underwritten
public offering, a letter dated the date of the closing under the underwriting agreement) signed by the independent registered
public accounting firm which has issued a report on the Company’s financial statements included in such registration statement,
in each case covering substantially the same matters with respect to such registration statement (and the prospectus included therein)
and, in the case of such accountants’ letter, with respect to events subsequent to the date of such financial statements,
as are customarily covered in opinions of issuer’s counsel and in accountants’ letters delivered to underwriters in
underwritten public offerings of securities. The Company shall also deliver promptly to each Holder participating in the offering
requesting the correspondence and memoranda described below and to the managing underwriter, if any, copies of all correspondence
between the Commission and the Company, its counsel or auditors and all memoranda relating to discussions with the Commission or
its staff with respect to the registration statement and permit each Holder and underwriter to do such investigation, upon reasonable
advance notice, with respect to information contained in or omitted from the registration statement as it deems reasonably necessary
to comply with applicable securities laws or rules of FINRA. Such investigation shall include access to books, records and properties
and opportunities to discuss the business of the Company with its officers and independent auditors, all to such reasonable extent
and at such reasonable times as any such Holder shall reasonably request.

 

4.3.4       Underwriting
Agreement. The Company shall enter into an underwriting agreement with the managing underwriter(s), if any, selected by any
Holders whose Registrable Securities are being registered pursuant to this Section 4, which managing underwriter shall be reasonably
satisfactory to the Company. Such agreement shall be reasonably satisfactory in form and substance to the Company, each Holder
and such managing underwriters, and shall contain such representations, warranties and covenants by the Company and such other
terms as are customarily contained in agreements of that type used by the managing underwriter. The Holders shall be parties to
any underwriting agreement relating to an underwritten sale of their Registrable Securities and may, at their option, require that
any or all the representations, warranties and covenants of the Company to or for the benefit of such underwriters shall also be
made to and for the benefit of such Holders. Such Holders shall not be required to make any representations or warranties to or
agreements with the Company or the underwriters except as they may relate to such Holders, their Shares and their intended methods
of distribution.

 

4.3.5       Documents
to be Delivered by Holder(s). Each of the Holder(s) participating in any of the foregoing offerings shall furnish to the Company
a completed and executed questionnaire provided by the Company requesting information customarily sought of selling security holders.

 

4.3.6       Damages.
Should the registration or the effectiveness thereof required by Sections 4.1 and 4.2 hereof be delayed by the Company or the Company
otherwise fails to comply with such provisions, the Holder(s) shall, in addition to any other legal or other relief available to
the Holder(s), be entitled to obtain specific performance or other equitable (including injunctive) relief against the threatened
breach of such provisions or the continuation of any such breach, without the necessity of proving actual damages and without the
necessity of posting bond or other security.

 

    	5

    	 

    

  

5.           New
Purchase Warrants to be Issued.

 

5.1         Partial
Exercise or Transfer. Subject to the restrictions in Section 3 hereof, this Purchase Warrant may be exercised or assigned in
whole or in part. In the event of the exercise or assignment hereof in part only, upon surrender of this Purchase Warrant for cancellation,
together with the duly executed exercise or assignment form and funds sufficient to pay any Exercise Price and/or transfer tax
if exercised pursuant to Section 2.1 hereto, the Company shall cause to be delivered to the Holder without charge a new Purchase
Warrant of like tenor to this Purchase Warrant in the name of the Holder evidencing the right of the Holder to purchase the number
of Shares purchasable hereunder as to which this Purchase Warrant has not been exercised or assigned.

 

5.2         Lost Certificate.
Upon receipt by the Company of evidence satisfactory to it of the loss, theft, destruction or mutilation of this Purchase Warrant
and of reasonably satisfactory indemnification or the posting of a bond, the Company shall execute and deliver a new Purchase Warrant
of like tenor and date. Any such new Purchase Warrant executed and delivered as a result of such loss, theft, mutilation or destruction
shall constitute a substitute contractual obligation on the part of the Company.

 

6.           Adjustments.

 

6.1         Adjustments
to Exercise Price and Number of Securities. The Exercise Price and the number of Shares underlying the Purchase Warrant shall
be subject to adjustment from time to time as hereinafter set forth:

 

6.1.1      Share
Dividends; Split Ups. If, after the date hereof, and subject to the provisions of Section 6.3 below, the number of outstanding
Shares is increased by a stock dividend payable in Shares or by a split up of Shares or other similar event, then, on the effective
day thereof, the number of Shares purchasable hereunder shall be increased in proportion to such increase in outstanding Shares,
and the Exercise Price shall be proportionately decreased.

 

6.1.2       Aggregation
of Shares. If, after the date hereof, and subject to the provisions of Section 6.3 below, the number of outstanding Shares
is decreased by a consolidation, combination or reclassification of Shares or other similar event, then, on the effective date
thereof, the number of Shares purchasable hereunder shall be decreased in proportion to such decrease in outstanding Shares, and
the Exercise Price shall be proportionately increased.

 

6.1.3       Replacement
of Securities upon Reorganization, etc. In case of any reclassification or reorganization of the outstanding Shares other than
a change covered by Section 6.1.1 or 6.1.2 hereof or that solely affects the par value of such Shares, or in the case of any share
reconstruction or amalgamation or consolidation of the Company with or into another corporation (other than a consolidation or
share reconstruction or amalgamation in which the Company is the continuing corporation and that does not result in any reclassification
or reorganization of the outstanding Shares), or in the case of any sale or conveyance to another corporation or entity of the
property of the Company as an entirety or substantially as an entirety in connection with which the Company is dissolved, the Holder
of this Purchase Warrant shall have the right thereafter (until the expiration of the right of exercise of this Purchase Warrant)
to receive upon the exercise hereof, for the same aggregate Exercise Price payable hereunder immediately prior to such event, the
kind and amount of shares of stock or other securities or property (including cash) receivable upon such reclassification, reorganization,
share reconstruction or amalgamation, or consolidation, or upon a dissolution following any such sale or transfer, by a Holder
of the number of Shares of the Company obtainable upon exercise of this Purchase Warrant immediately prior to such event; and if
any reclassification also results in a change in Shares covered by Section 6.1.1 or 6.1.2, then such adjustment shall be made pursuant
to Sections 6.1.1, 6.1.2 and this Section 6.1.3. The provisions of this Section 6.1.3 shall similarly apply to successive reclassifications,
reorganizations, share reconstructions or amalgamations, or consolidations, sales or other transfers.

 

    	6

    	 

    

  

6.1.4       Changes
in Form of Purchase Warrant. This form of Purchase Warrant need not be changed because of any change pursuant to this Section
6.1, and Purchase Warrants issued after such change may state the same Exercise Price and the same number of Shares as are stated
in the Purchase Warrants initially issued pursuant to this Agreement. The acceptance by any Holder of the issuance of new Purchase
Warrants reflecting a required or permissive change shall not be deemed to waive any rights to an adjustment occurring after the
Commencement Date or the computation thereof.

 

6.2         Substitute
Purchase Warrant. In case of any consolidation of the Company with, or share reconstruction or amalgamation of the Company
with or into, another corporation (other than a consolidation or share reconstruction or amalgamation which does not result in
any reclassification or change of the outstanding Shares), the corporation formed by such consolidation or share reconstruction
or amalgamation shall execute and deliver to the Holder a supplemental Purchase Warrant providing that the holder of each Purchase
Warrant then outstanding or to be outstanding shall have the right thereafter (until the stated expiration of such Purchase Warrant)
to receive, upon exercise of such Purchase Warrant, the kind and amount of shares of stock and other securities and property receivable
upon such consolidation or share reconstruction or amalgamation, by a holder of the number of Shares of the Company for which such
Purchase Warrant might have been exercised immediately prior to such consolidation, share reconstruction or amalgamation, sale
or transfer. Such supplemental Purchase Warrant shall provide for adjustments which shall be identical to the adjustments provided
for in this Section 6. The above provision of this Section shall similarly apply to successive consolidations or share reconstructions
or amalgamations.

 

6.3         Elimination of Fractional
Interests. The Company shall not be required to issue certificates representing fractions of Shares upon the exercise of the
Purchase Warrant, nor shall it be required to issue scrip or pay cash in lieu of any fractional interests, it being the intent
of the parties that all fractional interests shall be eliminated by rounding any fraction up or down, as the case may be, to the
nearest whole number of Shares or other securities, properties or rights.

 

7.           Reservation and Listing.
The Company shall at all times reserve and keep available out of its authorized Shares, solely for the purpose of issuance upon
exercise of the Purchase Warrants, such number of Shares or other securities, properties or rights as shall be issuable upon the
exercise thereof. The Company covenants and agrees that, upon exercise of the Purchase Warrants and payment of the Exercise Price
therefor, in accordance with the terms hereby, all Shares and other securities issuable upon such exercise shall be duly and validly
issued, fully paid and non-assessable and not subject to preemptive rights of any shareholder. The Company further covenants and
agrees that upon exercise of the Purchase Warrants and payment of the exercise price therefor, all Shares and other securities
issuable upon such exercise shall be duly and validly issued, fully paid and non-assessable and not subject to preemptive rights
of any shareholder. As long as the Purchase Warrants shall be outstanding, the Company shall use its commercially reasonable efforts
to cause all Shares issuable upon exercise of the Purchase Warrants to be listed (subject to official notice of issuance) on all
national securities exchanges (or, if applicable, on the OTC Bulletin Board or any successor trading market) on which the Shares
issued to the public in the Offering may then be listed and/or quoted.

 

    	7

    	 

    

 

8.           Certain
Notice Requirements.

 

8.1           Holder’s
Right to Receive Notice. Nothing herein shall be construed as conferring upon the Holders the right to vote or consent or to
receive notice as a shareholder for the election of directors or any other matter, or as having any rights whatsoever as a shareholder
of the Company. If, however, at any time prior to the expiration of the Purchase Warrants and their exercise, any of the events
described in Section 8.2 shall occur, then, in one or more of said events, the Company shall give written notice of such event
at least fifteen days prior to the date fixed as a record date or the date of closing the transfer books for the determination
of the shareholders entitled to such dividend, distribution, conversion or exchange of securities or subscription rights, or entitled
to vote on such proposed dissolution, liquidation, winding up or sale. Such notice shall specify such record date or the date of
the closing of the transfer books, as the case may be. Notwithstanding the foregoing, the Company shall deliver to each Holder
a copy of each notice given to the other shareholders of the Company at the same time and in the same manner that such notice is
given to the shareholders.

 

8.2           Events Requiring
Notice. The Company shall be required to give the notice described in this Section 8 upon one or more of the following events:
(i) if the Company shall take a record of the holders of its Shares for the purpose of entitling them to receive a dividend or
distribution payable otherwise than in cash, or a cash dividend or distribution payable otherwise than out of retained earnings,
as indicated by the accounting treatment of such dividend or distribution on the books of the Company, (ii) the Company shall offer
to all the holders of its Shares any additional shares of capital stock of the Company or securities convertible into or exchangeable
for shares of capital stock of the Company, or any option, right or warrant to subscribe therefor, or (iii) a dissolution, liquidation
or winding up of the Company (other than in connection with a consolidation or share reconstruction or amalgamation) or a sale
of all or substantially all of its property, assets and business shall be proposed.

 

8.3           Notice of
Change in Exercise Price. The Company shall, promptly after an event requiring a change in the Exercise Price pursuant to Section
6 hereof, send notice to the Holders of such event and change (“Price Notice”). The Price Notice shall describe
the event causing the change and the method of calculating same and shall be certified as being true and accurate by the Company’s
Chief Financial Officer.

 

8.4           Transmittal
of Notices. All notices, requests, consents and other communications under this Purchase Warrant shall be in writing and shall
be deemed to have been duly made when hand delivered, or mailed by express mail or private courier service: (i) if to the registered
Holder of the Purchase Warrant, to the address of such Holder as shown on the books of the Company, or (ii) if to the Company,
to following address or to such other address as the Company may designate by notice to the Holders:

 

If to the Holder:

 

Aegis Capital Corp.

810 Seventh Avenue, 11th Floor

New York, New York 10019

Attn: Mr. David Bocchi, Managing Director of Investment Banking

Fax No.: (212) 813-1047

 

with a copy (which shall not constitute notice) to:

Bryan Cave LLP

One Metropolitan Square

211 North Broadway, Suite 3600

St. Louis, Missouri 63102-2750

Attn: Todd M. Kaye

 

    	8

    	 

    

  

Fax No.:  314-552-8194

 

If to the Company:

 

Cryoport, Inc.

20382 Barents Sea Circle

Lake Forest, California 92630

Attention: Robert Stefanovich, CFO

 

with a copy (which shall not constitute notice) to:

 

Snell & Wilmer L.L.P.

600 Anton Boulevard, Suite 1400

Costa Mesa, California 92626

Attention: Tony Ippolito

Fax No: 714-427-7799

 

9.           Miscellaneous.

 

9.1           Amendments.
The Company and Aegis may from time to time supplement or amend this Purchase Warrant without the approval of any of the Holders
in order to cure any ambiguity, to correct or supplement any provision contained herein that may be defective or inconsistent with
any other provisions herein, or to make any other provisions in regard to matters or questions arising hereunder that the Company
and Aegis may deem necessary or desirable and that the Company and Aegis deem shall not adversely affect the interest of the Holders.
All other modifications or amendments shall require the written consent of and be signed by the party against whom enforcement
of the modification or amendment is sought.

 

9.2           Headings.
The headings contained herein are for the sole purpose of convenience of reference, and shall not in any way limit or affect the
meaning or interpretation of any of the terms or provisions of this Purchase Warrant.

 

9.3.          Entire
Agreement. This Purchase Warrant (together with the other agreements and documents being delivered pursuant to or in connection
with this Purchase Warrant) constitutes the entire agreement of the parties hereto with respect to the subject matter hereof, and
supersedes all prior agreements and understandings of the parties, oral and written, with respect to the subject matter hereof.

 

9.4           Binding
Effect. This Purchase Warrant shall inure solely to the benefit of and shall be binding upon, the Holder and the Company and
their permitted assignees, respective successors, legal representative and assigns, and no other person shall have or be construed
to have any legal or equitable right, remedy or claim under or in respect of or by virtue of this Purchase Warrant or any provisions
herein contained.

 

    	9

    	 

    

  

9.5           Governing
Law; Submission to Jurisdiction; Trial by Jury. This Purchase Warrant shall be governed by and construed and enforced in accordance
with the laws of the State of New York, without giving effect to conflict of laws principles thereof. The Company hereby agrees
that any action, proceeding or claim against it arising out of, or relating in any way to this Purchase Warrant shall be brought
and enforced in the New York Supreme Court, County of New York, or in the United States District Court for the Southern District
of New York, and irrevocably submits to such jurisdiction, which jurisdiction shall be exclusive. The Company hereby waives any
objection to such exclusive jurisdiction and that such courts represent an inconvenient forum. Any process or summons to be served
upon the Company may be served by transmitting a copy thereof by registered or certified mail, return receipt requested, postage
prepaid, addressed to it at the address set forth in Section 8 hereof. Such mailing shall be deemed personal service and shall
be legal and binding upon the Company in any action, proceeding or claim. The Company and the Holder agree that the prevailing
party(ies) in any such action shall be entitled to recover from the other party(ies) all of its reasonable attorneys’ fees
and expenses relating to such action or proceeding and/or incurred in connection with the preparation therefor. The Company (on
its behalf and, to the extent permitted by applicable law, on behalf of its stockholders and affiliates) and the Holder hereby
irrevocably waive, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding
arising out of or relating to this Agreement or the transactions contemplated hereby.

 

9.6           Waiver,
etc. The failure of the Company or the Holder to at any time enforce any of the provisions of this Purchase Warrant shall not
be deemed or construed to be a waiver of any such provision, nor to in any way affect the validity of this Purchase Warrant or
any provision hereof or the right of the Company or any Holder to thereafter enforce each and every provision of this Purchase
Warrant. No waiver of any breach, non-compliance or non-fulfillment of any of the provisions of this Purchase Warrant shall be
effective unless set forth in a written instrument executed by the party or parties against whom or which enforcement of such waiver
is sought; and no waiver of any such breach, non-compliance or non-fulfillment shall be construed or deemed to be a waiver of any
other or subsequent breach, non-compliance or non-fulfillment.

 

9.7           Execution
in Counterparts. This Purchase Warrant may be executed in one or more counterparts, and by the different parties hereto in
separate counterparts, each of which shall be deemed to be an original, but all of which taken together shall constitute one and
the same agreement, and shall become effective when one or more counterparts has been signed by each of the parties hereto and
delivered to each of the other parties hereto. Such counterparts may be delivered by facsimile transmission or other electronic
transmission.

 

9.8           Exchange
Agreement. As a condition of the Holder’s receipt and acceptance of this Purchase Warrant, Holder agrees that, at any
time prior to the complete exercise of this Purchase Warrant by Holder, if the Company and Aegis enter into an agreement (“Exchange
Agreement”) pursuant to which they agree that all outstanding Purchase Warrants will be exchanged for securities or cash
or a combination of both, then Holder shall agree to such exchange and become a party to the Exchange Agreement.

 

[Signature Page Follows]

 

    	10

    	 

    

  

IN WITNESS WHEREOF,
the Company has caused this Purchase Warrant to be signed by its duly authorized officer as of the ____ day of _______, 2015.

 

	CRYOPORT, INC.	 
	 	 
	By:	 	 
	 	Name:	 
	 	Title:	 

 

    	11

    	 

    

  

[Form to be used to exercise Purchase
Warrant]

 

Date: __________, 20___

 

The undersigned
hereby elects irrevocably to exercise the Purchase Warrant for ______ shares of common stock, par value $0.001 per share (the “Shares”),
of Cryoport, Inc., a Nevada corporation (the “Company”), and hereby makes payment of $____ (at the rate of $____
per Share) in payment of the Exercise Price pursuant thereto. Please issue the Shares as to which this Purchase Warrant is exercised
in accordance with the instructions given below and, if applicable, a new Purchase Warrant representing the number of Shares for
which this Purchase Warrant has not been exercised.

 

or

 

The undersigned
hereby elects irrevocably to convert its right to purchase ___ Shares of the Company under the Purchase Warrant for ______ Shares,
as determined in accordance with the following formula:

 

	 	X	=	Y(A-B)	 
	A	 

 

	Where,	 	 	 
	 	X	=	The number of Shares to be issued to Holder;
	 	Y	=	The number of Shares for which the Purchase Warrant is being exercised;
	 	A	=	The fair market value of one Share which is equal to $_____; and
	 	B	=	The Exercise Price which is equal to $______ per share

 

The undersigned
agrees and acknowledges that the calculation set forth above is subject to confirmation by the Company and any disagreement with
respect to the calculation shall be resolved by the Company in its sole discretion.

 

Please issue
the Shares as to which this Purchase Warrant is exercised in accordance with the instructions given below and, if applicable, a
new Purchase Warrant representing the number of Shares for which this Purchase Warrant has not been converted.

 

Signature                                                                                              

 

Signature Guaranteed
                                                                         

 

    	12

    	 

    

  

	INSTRUCTIONS FOR REGISTRATION OF SECURITIES	 
	 	 
	Name:	 	 
	 	(Print in Block Letters)	 
	 	 	 
	Address:	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 

 

NOTICE: The signature
to this form must correspond with the name as written upon the face of the Purchase Warrant without alteration or enlargement or
any change whatsoever, and must be guaranteed by a bank, other than a savings bank, or by a trust company or by a firm having membership
on a registered national securities exchange.

 

    	13

    	 

    

  

[Form to be used to assign Purchase Warrant]

 

ASSIGNMENT

 

(To be executed by the registered Holder
to effect a transfer of the within Purchase Warrant):

 

FOR VALUE RECEIVED, __________________
does hereby sell, assign and transfer unto the right to purchase shares of common stock, par value $0.001 per share, of Cryoport,
Inc., a Nevada corporation (the “Company”), evidenced by the Purchase Warrant and does hereby authorize the
Company to transfer such right on the books of the Company.

 

Dated: __________, 20__

 

Signature                                                                                       

 

Signature Guaranteed                                                                  

 

NOTICE: The signature to this form must
correspond with the name as written upon the face of the within Purchase Warrant without alteration or enlargement or any change
whatsoever, and must be guaranteed by a bank, other than a savings bank, or by a trust company or by a firm having membership on
a registered national securities exchange.

 

    	14

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00246-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00246-of-00352.parquet"}]]